$61.09
2.28%
Nasdaq, Jun 28, 10:04 pm CET
ISIN
US74276L1052
Symbol
PRCT
Sector

PROCEPT BioRobotics Share price

$61.09
-3.39 5.26% 1M
+18.14 42.24% 6M
+19.18 45.76% YTD
+26.25 75.34% 1Y
+19.15 45.66% 3Y
+19.15 45.66% 5Y
+19.15 45.66% 10Y
Nasdaq, Closing price Fri, Jun 28 2024
ISIN
US74276L1052
Symbol
PRCT
Sector

Key figures

Market capitalization $3.14b
Enterprise Value $3.00b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 19.17
P/S ratio (TTM) P/S ratio 20.10
P/B ratio (TTM) P/B ratio 11.89
Sales growth (TTM) Sales growth 83.44%
Turnover (TTM) Turnover $156.33m
EBIT (operating result TTM) EBIT $-108.44m
Free cash flow (TTM) Free cash flow $-126.17m
Cash position $225.58m
EPS (TTM) EPS $-2.12
P/E ratio expected negative
P/S ratio expected 14.70
EV/Sales expected 14.02
Short interest 12.01%
Show more

Is PROCEPT BioRobotics a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

PROCEPT BioRobotics Share analysis

Unlock scores for free

Analyst opinions

9 Analysts have issued a PROCEPT BioRobotics forecast:

8x Buy
89%
1x Hold
11%

Analyst opinions

9 Analysts have issued a PROCEPT BioRobotics forecast:

Buy
89%
Hold
11%

Financial data from PROCEPT BioRobotics

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
156 156
83% 83%
100%
- Direct costs 77 77
64% 64%
49%
80 80
107% 107%
51%
- Selling and administrative expenses 137 137
44% 44%
88%
- Research and development costs 47 47
49% 49%
30%
-104 -104
18% 18%
-67%
- Depreciation and amortization 4.02 4.02
20% 20%
3%
EBIT (operating result) EBIT -108 -108
16% 16%
-69%
Net profit -103 -103
5% 5%
-66%

Figures in millions USD.

Don't miss a thing! We will send you all news about the PROCEPT BioRobotics share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

PROCEPT BioRobotics Share News

Positive
InvestorPlace
3 days ago
Right now, growth investors are focused primarily on opportunities in the semiconductors and artificial intelligence stocks space. That's understandable, given how fast technology is advancing in those areas right now.
Neutral
GlobeNewsWire
13 days ago
SAN JOSE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, announced today that the American Medical Association (“AMA”) has established a new Current Procedural Terminology (“CPT”) Category I code for transurethral waterjet r...
Neutral
GlobeNewsWire
27 days ago
SAN JOSE, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced that members of management will present at the upcoming 2024 Truist Securities MedTech Conference in Boston, Massachusetts. Management is scheduled to present on T...
More PROCEPT BioRobotics News

Company profile

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in Redwood City, CA.

Head office United States
CEO Reza Zadno
Employees 626
Founded 2007
Website www.procept-biorobotics.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now